LYMIT-DIS Second Meeting: September 2018

LYMIT-DIS Second Meeting: September 2018

Pamplona, Spain: 2nd Meeting of the LYMIT-DIS consortium

The team members met on 19th-21st of September 2018 at the CIMA institute in Pamplona, Spain hosted by Partner 5 leader Dr Arantxa Gonzalez-Miqueo.

The Meeting was dedicated to intense & dynamic exchanges on the advancement of Project tasks and deliverables, with special focus on stimulating exchanges of methods and materials between our different teams to further advance the work packages.

Participants:

  • Partner 1: Ebba Brakenhielm & Paul Mulder
  • Partner 2: Marc van Bilsen & Annika Kuhn
  • Partner 3: Anna Ratajska
  • Partner 4: Liz Jones & Steven Simmonds & Ilona Cuijpers
  • Partner 5: Arantxa Gonzales Miqueo & Javier Díez & Begoña López & Ujué Moreno & Susana Ravassa

 LYMIT DISPamplonaheart

Read more

March 6th  LYMIT-DIS project official start date as one out of 14 European Project selected by ERA-CVD in 2016

March 6th LYMIT-DIS project official start date as one out of 14 European Project selected by ERA-CVD in 2016

ERA-NET on Cardio Vascular Diseases (ERA-CVD)

Cardiovascular diseases (CVD) are the major cause of death in Europe. CVD research is a crucial area in health research, hence an effective coordination of research at national and EU level, increased cross-disciplinary interaction and research advancements are needed. By gathering their forces and funding capacities so far 18 countries joined to set up a new ERA-Net Cofund action (European Research Area Network co-funded by the European Commission, EC) dedicated to cardiovascular diseases (ERA-CVD) .

Read more

September 20-21st LYMIT-DIS Kick-off meeting takes place in Rouen, France

September 20-21st LYMIT-DIS Kick-off meeting takes place in Rouen, France

Des chercheurs normands au chevet de cardiaques

Santé. À Rouen, un laboratoire a remporté un appel d’offres européen pour diriger un projet scientifique sur l’insuffisance cardiaque. Avec l’espoir de traiter la maladie.

Read more

LYMIT-DIS

Targeted Lymphatic and Microvessel Treatments in metabolic-DISease HFpEF

Réalisation Internet Bordeaux.

Contact Us

Legal mentions